RxDoctor Payments Data

Amy Redmer, MD

Family Medicine · Shiloh, ILNPI 1982676698

Payments from drug & device makers

$3,959in general payments, 2019–2025

Across 217 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$676
  • Lilly USA, LLC$427
  • Novo Nordisk$375
  • Pfizer$274
  • Amgen$192
  • plus $783 from 12 others

What the payments were for

  • Food & beverage$3,959100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,959 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$113,217
Medicare patients
240
Services billed
2,652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban66$84,488
OzempicSemaglutide41$53,781
RybelsusSemaglutide21$50,582
FarxigaDapagliflozin Propanediol48$41,819
JardianceEmpagliflozin20$31,458
XareltoRivaroxaban13$18,583
JanuviaSitagliptin Phosphate16$18,520
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$11,667
Semglee (Yfgn) PenInsulin Glargine-Yfgn13$9,270
Breo ElliptaFluticasone/Vilanterol12$5,043
Atorvastatin Calcium474$4,613
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$3,889
SymbicortBudesonide/Formoterol Fumarate12$3,828
Gabapentin150$3,629
Albuterol Sulfate HfaAlbuterol Sulfate114$3,422

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$375$104,36462 claims
PfizerEliquis$274$84,48866 claims
AstraZenecaFarxiga, Symbicort$676$45,64760 claims
Boehringer IngelheimJardiance$60$31,45820 claims
AbbVieSynthroid$1,231$1,68421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Shiloh

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →